Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: A reappraisal of paraneoplastic pemphigus

Archives of Dermatology

Volumn 137, Issue 2, 2001, Pages 193-206

  Nguyen, Vu Thuong ^a   Ndoye, Assane ^a   Bassler, Karl D ^a   Shultz, Leonard D ^b   Shields, Molly C ^a   Ruben, Beth S ^a   Webber, Robert J ^c   Pittelkow, Mark R ^d   Lynch, Peter J ^a   Grando, Sergei A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JACKSON LABORATORY   (United States)

^c Research and Diagnostic Antibodies   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISONE;

ADULT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CELLULAR IMMUNITY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PARANEOPLASTIC SYNDROME; PEMPHIGUS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, SURFACE; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELL ADHESION MOLECULES; CYTOSKELETAL PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; DESMOGLEIN 1; DESMOGLEIN 3; DESMOGLEINS; DESMOPLAKINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; LICHENOID ERUPTIONS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; PHENOTYPE; RESPIRATORY MUCOSA; SKIN;

EID: 0035113283     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (101)

1. Paraneoplastic pemphigus: An autoimmune mucocutaneous disease associated with neoplasia
2. Noninfectious vesicobullous and vesicopustular diseases
3. Paraneoplastic pemphigus as the presenting symptom of a lymphoma of the tongue
4. Pemphigus foliaceus and oral lichen planus in a patient with systemic lupus erythematosus and thymoma
5. Graft-versus-host-like mucocutaneous eruptions with serological features of paraneopiastic pemphigus and systemic lupus erythematosus in a patient with non-Hodgkin's lymphoma
6. Retroperitoneal round-cell liposarcoma associated with paraneoptastic pemphigus presenting as lichen planus pemphigoides-like eruption
7. Bullouspemphigoid in association with cutaneous lesions specific to a myelodysplastic syndrome
8. Paraneoplastic pemphigus with clinical features of erosive lichen planus associated with Castleman's tumor
9. Paraneoplastic pemphigus in the absence of a known neoplasm
10. Histologic features of paraneoplastic pemphigus
11. Paraneoplastic pemphigus: A report of three cases including one long-term survivor
12. Paraneoplastic pemphigus presenting as a lichen planus pemphigoides-like eruption
13. Lichen planus
14. Syngeneic or autologous graft-versus-host disease
15. T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction
16. Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus
17. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice
18. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Pemphigus vulgaris and foliaceus patients develop antibodies against keratinocyte cholinergic receptors
19. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris
20. The mechanism of respiratory failure in paraneoplastic pemphigus
21. The mechanism of respiratory failure in paraneoplastic pemphigus
22. Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft-versus-host disease
23. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine
24. Evidence for cell-mediated immune mechanisms in the pathology of pemphigus
25. The interleukin-2 receptor in lesions and serum of bullous pemphigoid
26. Role of cell-mediated immune reaction in blister formation of bullous pemphigoid
27. Mononuclear cell infiltrates in bullous disease
28. T- and B-lymphocytes in pemphigus vulgaris: A clinicoimmunological follow-up study of fifty patients with pemphigus vulgaris
29. Local involvement of antigen-presenting cells and activated T cells in perilesional and clinically uninvolved skin in pemphigus vulgaris
30. Autoreactive cytotoxic T lymphocytes in pemphigus and pemphigoid
31. Immunofluorescence tests: Clinical significance of sera and skin in bullous diseases
32. Identification and mapping of keratinocyte muscarinic acetylcholine receptor subtypes in human epidermis
33. Keratinocyte muscarinic acetylcholine receptors: Immunolocalization and partial characterization
34. The calcium-sensitive epitope of pemphigus foliaceus antigen is present on a murine tryptic fragment and constitutes a major antigenic region for human autoantibodies
35. Pemphigus vulgaris antibody identifies pemphaxin: A novel keratinocyte annexin-like molecule binding acetylcholine
36. Desmoglein 3-ELISA: A pemphigus vulgaris-specific diagnostic tool
37. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile
38. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus
39. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease
40. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris
41. Paraneoplastic pemphigus
42. Human autoantibodies against a desmosomal core protein in pemphigus foliaceus
43. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion
44. Patterns of cell death: The significance of apoptosis for dermatology
45. Apoptosis in lichen planus and several other dermatoses: Intra-epidermal cell death with filamentous degeneration
46. Nitric oxide in inflammation and immune response
47. Induction of nitric oxide synthase is involved in the mechanism of Fas-mediated apoptosis in haemopoietic cells
48. Expression of markers of differentiation in normal bronchial epithelium and bronchial dysplasia
49. Cytokeratins in normal lung and lung carcinomas, I: Adenocarcinomas, squamous cell carcinomas and cultured cell lines
50. Expression of intermediate filament proteins in fetal and adult human lung tissues
51. Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma
52. Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation
53. Constrictive bronchiolitis obliterans and paraneoplastic pemphigus
54. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans
55. Bronchiolitis obliterans with pemphigus vulgaris and Castleman's disease of hyaline-vascular type: An autopsy case analyzed by computer-aided 3-D reconstruction of the airway lesions
56. Pemphigus vulgaris and malignancy
57. Internal disorders associated with bullous disease of the skin: A critical review
58. Paraneoplastic syndromes
59. Paraneoplastic neuropathy
60. Oral pemphigus vulgaris: A review of the literature and a report on the management of 12 cases
61. Pemphigus: Diseases of antidesmosomal autoimmunity
62. The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin
63. Plectin serves as an autoantigen in paraneoplastic pemphigus
64. Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease
65. New paths in human cancer serology
66. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer
67. Sequence-specific RNA binding by a Nova KH domain: Implications for paraneoplastic disease and the fragile X syndrome
68. Mechanisms of paraneoplastic neurologic syndromes
69. Immune surveillance: Paraneoplastic or environmental triggers of autoimmunity
70. Coupling and uncoupling of tumor immunity and autoimmunity
71. Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies
72. Cytotoxic T cells react with recombinant Y protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody
73. Tumor specific killer ceils in paraneoplastic cerebellar degeneration
74. Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus
75. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions
76. Autoimmunity to keratinocyte acetylcholine receptors in pemphigus
77. Periplakin and envoplakin are target antigens in canine and human paraneoplastic pemphigus
78. Novel human alpha 9 acetylcholine receptor regulating keratinocyte adhesion is targeted by pemphigus vulgaris autoimmunity
79. Pemphigus antibodies and shedding snake serum enhance susceptibility of epidermal keratinocytes in natural cytotoxic reactions
80. Lysis of squamous cell carcinoma via antibody-dependent cellular cytotoxicity
81. Immune response to chronic myeloid leukaemia
82. Lymphocyte-mediated cytolysis and disease
83. IL-6 enhances the cytotoxic activity of thymocyte-derived CD56 positive cells
84. In vitro expansion of tumor-specific, HLA-restricted human CD8+ cytolytic T lymphocytes
85. Elevated serum levels of interleukin-6 in paraneoplastic pemphigus
86. The Fc gamma receptor of natural killer cells is a phospholipid-linked membrane protein
87. Effect of rlFNγ on antibody-mediated cytotoxicity via human monocyte IgG Fc receptor II (CD32)
88. Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans
89. Antibody-dependent cell-mediated immune reactions: Fundamentals and clinico-diagnostic relevance
90. Necrotizing tracheobronchitis with progressive airflow obstruction associated with paraneoplastic pemphigus
91. Constrictive (obliterative) bronchiolitis: Diagnosis, etiology, and a critical review of the literature
92. The inflammatory and cytotoxic effects of a nitric oxide releasing cream on normal skin
93. Apoptosis as a mechanism of lectindependent monocyte-mediated cytotoxicity
94. Involvement of nitric oxide in target-cell lysis and DNA fragmentation induced by murine natural killer cells
95. Nitric oxide sensitizes ovarian tumor cells to Fasinduced apoptosis
96. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus
97. Stimulating effect of pemphigus antibodies upon interleukin inhibitor production by normal human epidermocytes
98. Interleukin cascade reaction inhibition by supernatants of the cultures of antibody-transformed human basal keratinocytes
99. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes
100. Lichenoid dermatitis in paraneoplastic pemphigus: A pathogenic trigger of epitope spreading?
101. Epitope spreading in paraneoplastic pemphigus: Autoimmune induction in antibody-mediated blistering skin diseases